Financial Ratios

SANGAM HEALTH CARE PRODUCTS LTD.

NSE : NABSE : 531625ISIN CODE : INE431E01011Industry : Hospital & Healthcare ServicesHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
Select year
ParticularsMar2021Mar2020Mar2019Mar2018Mar2017
Operational & Financial Ratios
   Earnings Per Share (Rs)-1.552.73-1.364.96-4.61
   CEPS(Rs)-0.733.57-0.355.99-3.59
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)-12.26-10.71-18.62-14.42-20.65
   Tax Rate(%)11.27-18.697.0017.43-0.24
Margin Ratios
   Core EBITDA Margin(%)-12.378.354.06-19.97-1.52
   EBIT Margin(%)-23.6415.24-0.3552.91-7.00
   Pre Tax Margin(%)-24.3414.03-9.2938.54-26.74
   PAT Margin (%)-21.6016.65-8.6431.82-26.80
   Cash Profit Margin (%)-10.1621.80-2.2438.40-20.85
Performance Ratios
   ROA(%)-20.5422.07-8.8329.43-22.61
   ROE(%)0.000.000.000.000.00
   ROCE(%)-301.870.000.001025.16-21.76
   Asset Turnover(x)0.951.331.020.920.84
   Sales/Fixed Asset(x)0.360.650.520.520.57
   Working Capital/Sales(x)-0.46-1.18-0.65-1.30-1.54
Efficiency Ratios
   Fixed Capital/Sales(x)2.771.531.921.941.75
   Receivable days20.396.352.760.511.36
   Inventory Days81.7948.6128.5545.1083.27
   Payable days333.61183.83184.61130.92185.08
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)0.000.000.000.000.00
   Price/Book(x)0.000.000.000.000.00
   Yield(%)
   EV/Net Sales(x)3.461.491.711.522.15
   EV/Core EBITDA(x)-25.436.5325.292.32-192.70
   EV/EBIT(x)-13.138.74-443.302.61-29.01
   EV/CE(x)3.512.501.511.441.86
   M Cap / Sales0.000.000.000.000.00
Growth Ratio
   Net Sales Growth(%)-56.263.640.21-13.121.89
   Core EBITDA Growth(%)-126.16249.33-89.695210.72-107.12
   EBIT Growth(%)-167.824675.21-100.66784.36-179.22
   PAT Growth(%)-156.70299.91-127.50207.54-345.64
   EPS Growth(%)-156.70299.91-127.50207.54-345.64
Financial Stability Ratios
   Total Debt/Equity(x)-1.00-1.10-0.76-0.80-1.21
   Current Ratio(x)0.140.240.120.100.23
   Quick Ratio(x)0.100.100.050.050.01
   Interest Cover(x)-33.9012.60-0.043.68-0.35
   Total Debt/Mcap(x)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.